Advertisements


Roche"s Child Arthritis Drug"s New Formulation Gets FDA Nod

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

Roche Gets FDA Approval for New Formulation of Asthma Drug

Roche (RHHBY) receives FDA approval for a dose prefilled syringe (PFS) formulation of its asthma drug, Xolair. Roche Holding AG RHHBY announced that the FDA has approved expansion prefilled .....»»

Category: dealsSource: nytOct 1st, 2018

J&J"s (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study

J&J's (JNJ) Tremfya meets the primary endpoint in a late stage study that evaluated the efficacy and safety of the drug.....»»

Category: dealsSource: nyt9 hr. 35 min. ago

Roche Extends Deadline For Spark Acquisition As US, UK Regulators Seek Additional Information

Swiss drug giant Roche Holdings AG Basel ADR (OTC: RHHBY) has announced another delay in its proposed takeover of the gene therapy biotech Spark Therapeutics Inc (NASDAQ: ONCE). read more.....»»

Category: blogSource: benzingaJun 10th, 2019

Pfizer had clues its drug could prevent Alzheimer’s. It didn’t report the findings.

Researchers say Pfizer should have published its analysis on the blockbuster rheumatoid arthritis therapy Enbrel. Pfizer says its decision was based on science......»»

Category: topSource: washpostJun 5th, 2019

Pfizer had clues its drug could prevent Alzheimer"s. What happened?

The company’s rheumatoid arthritis drug appeared to reduce the risk of getting Alzheimer’s disease by 64 percent. The Washington Post’s Chris Rowland explains why Pfizer did not pursue it......»»

Category: topSource: moneycentralJun 5th, 2019

These 3 Major Drug Manufacturers Are Strong Performers

Roche tops the listRelated Stocks: RHHBY, MRK, NVS,.....»»

Category: dealsSource: nytMay 21st, 2019

Madison biotech company spun from Roche raises $10M

Nimble Therapeutics is using the financing to commercialize its chemical synthesis technology for drug development......»»

Category: topSource: bizjournalsApr 30th, 2019

The Daily Biotech Pulse: Mixed Results For Merck"s Keytruda In Stomach Cancer; Roche"s Spark-Buy Delayed, Teva Recalls Hypertension Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) read more.....»»

Category: blogSource: benzingaApr 26th, 2019

AbbVie beats estimates as Humira sales fall less than feared

Drugmaker AbbVie Inc's quarterly revenue beat Wall Street estimates on Thursday, as the decline in sales of its blockbuster rheumatoid arthritis drug Humira was not as steep as expected......»»

Category: topSource: reutersApr 25th, 2019

Why Galapagos NV Stock Bolted Higher in March

Galapagos' experimental rheumatoid arthritis drug hit the mark in two late-stage studies last month......»»

Category: topSource: foxnewsApr 9th, 2019

Wall Street is buzzing about the Gilead’s rheumatoid arthritis drug. Here’s why

Shares of Belgium-based b.....»»

Category: topSource: marketwatchMar 29th, 2019

Wall Street is buzzing about Gilead’s rheumatoid arthritis drug. Here’s why

Shares of Belgium-based b.....»»

Category: topSource: marketwatchMar 29th, 2019

Wall Street is buzzing about Gilead’s new rheumatoid arthritis drug. Here’s why

Shares of Belgium-based b.....»»

Category: topSource: marketwatchMar 29th, 2019

AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal

AstraZeneca Plc will pay up to $6.9 billion to work with Daiichi Sankyo Co Ltd on a hotly-tipped experimental treatment for breast cancer, in a direct challenge to the world's biggest cancer drug maker Roche......»»

Category: topSource: reutersMar 29th, 2019

Jazz"s Xyrem Follow-On Drug Succeeds in Phase III Study

Jazz Pharmaceuticals (JAZZ) announced positive top-line data from its phase III study on low sodium formulation of Xyrem, JZP.....»»

Category: worldSource: nytMar 27th, 2019

Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices

Zacks.....»»

Category: topSource: redinewsMar 1st, 2019

Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus

Roche (RHHBY) announces encouraging data on multiple sclerosis (MS) drug Ocrevus which reinforced the efficacy of drug in the long run. Roche Holding AG RHHBY announced enco.....»»

Category: dealsSource: nytApr 23rd, 2018

Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 19th, 2018

Roche Hemophilia Drug Gets Breakthrough Therapy Designation

The FDA grants Breakthrough Therapy Designation to Roche's (RHHBY) Hemlibra for treatment of people with hemophilia A without factor VIII inhibitors. Roc.....»»

Category: personnelSource: nytApr 18th, 2018

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S. and foreign biotechnology and pharmaceutical companies......»»

Category: blogSource: 247wallstApr 17th, 2018